Diaceutics PLC Investor Relations

Investor Overview

At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharma companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by DXRX – The Diagnostic Network®.

DXRX is the world’s first diagnostic commercialization platform for precision medicine, integrating multiple pipelines of real-world diagnostic testing data from a global network of labs.

Diaceutics' data capability is one of the three key value drivers it has integrated into its unique DXRX platform alongside its global lab network and product suite tailored for precision testing.

Upcoming Events

2022

Release of Final Results FY21
22nd Mar
Group FY21 Results investor webinar
23rd Mar
Half Year End
30th Jun
Year End
31st Dec

Why invest in Diaceutics?

Have a question?

Upcoming Events

2022

Release of Final Results FY21
22nd Mar
Group FY21 Results investor webinar
23rd Mar
Half Year End
30th Jun
Year End
31st Dec

Why invest in Diaceutics?

Have a question?

Featured Investor News

Investor Alerts

If you would like to recieve investor email alerts, simply complete this form. If you have already subscribed, you can change your settings or unsubscribe here.